Insider Transactions in Q2 2022 at Health Catalyst, Inc. (HCAT)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 15
2022
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
648
-1.09%
|
$7,776
$12.2 P/Share
|
Jun 14
2022
|
Duncan Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
11,677
+36.4%
|
-
|
Jun 14
2022
|
John A Kane |
BUY
Grant, award, or other acquisition
|
Direct |
11,677
+11.36%
|
-
|
Jun 14
2022
|
Anita Pramoda |
BUY
Grant, award, or other acquisition
|
Direct |
11,677
+43.83%
|
-
|
Jun 14
2022
|
Julie Larson Green |
BUY
Grant, award, or other acquisition
|
Direct |
11,677
+30.36%
|
-
|
Jun 14
2022
|
S. Dawn Smith |
BUY
Grant, award, or other acquisition
|
Direct |
11,677
+30.36%
|
-
|
Jun 14
2022
|
Mark B Templeton |
BUY
Grant, award, or other acquisition
|
Direct |
11,677
+35.2%
|
-
|
Jun 06
2022
|
Daniel H. Orenstein General Counsel |
SELL
Open market or private sale
|
Direct |
2,838
-2.66%
|
$39,732
$14.85 P/Share
|
Jun 06
2022
|
Jason Alger Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
261
-0.69%
|
$3,654
$14.95 P/Share
|
Jun 01
2022
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,362
-0.82%
|
$103,068
$14.6 P/Share
|
Jun 01
2022
|
James Patrick Nelli Jr. President |
SELL
Payment of exercise price or tax liability
|
Direct |
3,359
-0.62%
|
$47,026
$14.6 P/Share
|
Jun 01
2022
|
Paul Horstmeier Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,542
-0.71%
|
$35,588
$14.6 P/Share
|
Jun 01
2022
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,687
-1.5%
|
$65,618
$14.6 P/Share
|
Jun 01
2022
|
Bryan Richard Hinton Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,413
-2.42%
|
$19,782
$14.6 P/Share
|
Jun 01
2022
|
Daniel H. Orenstein General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,224
-0.57%
|
$17,136
$14.6 P/Share
|
Jun 01
2022
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
848
-0.7%
|
$11,872
$14.6 P/Share
|
Jun 01
2022
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
567
-0.74%
|
$7,938
$14.6 P/Share
|
May 18
2022
|
Daniel D. Burton Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
89,988
+9.17%
|
$899,880
$10.8 P/Share
|
May 16
2022
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,860
-3.0%
|
$27,900
$15.87 P/Share
|
Apr 27
2022
|
Daniel H. Orenstein General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.44%
|
$50,000
$10.34 P/Share
|
Apr 18
2022
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,039
-1.6%
|
$44,858
$22.87 P/Share
|
Apr 12
2022
|
Paul Horstmeier Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,208
-2.81%
|
$130,200
$25.16 P/Share
|
Apr 12
2022
|
Paul Horstmeier Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,208
+0.92%
|
$72,912
$14.16 P/Share
|